Results

Overview for the year ended 30 June 2017 (NZ$)

•   Total revenue of $549.5 million – an increase of 56% over the prior corresponding period (pcp)
•   EBITDA1 of $141.2 million – 159% ahead of the pcp
•   EBITDA to sales margin of 26%, up from 15% on pcp
•   Net profit after tax of $90.6 million – 198% ahead of the pcp
•   Basic earnings per share (EPS) of 12.7 cents, an increase of 186% on pcp
•   Operating cash flow of $99.9 million and a cash balance of $121.0 million at year end
•   Continued strong growth in sales and market share for a2 Platinum® infant formula in Australia and China
•   Sales growth of a2 MilkTM branded fresh milk and milk powders in Australia
•   Increased investment in building brand awareness in the United States (US)
•   Positive operating earnings in the United Kingdom (UK)
•   Development of a broader nutritional products strategy and a new focus on emerging markets

Plus a share buyback up to NZD40 million and possible special dividend